文献速递产科母胎医学

抗生素治疗可根除部分早产且胎膜完整患者的羊膜腔内感染或炎症

Antibiotic administration can eradicate intra-amniotic infection or intra-amniotic inflammation in a subset of patients with preterm labor and intact membranes.
PubMed 文献 · Am J Obstet Gynecol · 2019-03-27

本研究纳入20至34周单胎早产且胎膜完整、经羊膜腔穿刺确诊羊膜腔内感染和/或炎症并接受头孢曲松、克拉霉素和甲硝唑联合治疗的孕妇,发现随访羊膜腔穿刺者中79%感染/炎症消退,84%治疗成功(感染/炎症消退或足月分娩),接受抗生素方案者治疗成功率为32%。

要点

  • 随访羊膜腔穿刺的19例中,15例(79%)羊膜腔内感染/炎症消退,16例(84%)达到治疗成功。
  • 接受抗生素方案的50例中,治疗成功16例(32%)。
  • 接受抗生素联合方案者羊膜腔穿刺至分娩中位时间显著长于未接受者(11.4天 vs 3.1天,P=.04)。

核心结论

  • 在早产、胎膜完整且合并羊膜腔内感染/炎症并接受随访羊膜腔穿刺的患者中,79%经抗生素治疗后感染/炎症得到根除。
  • 随访羊膜腔穿刺者治疗成功率为84%,接受抗生素方案者治疗成功率为32%。

研究设计与样本

  • 研究人群为20至34周单胎妊娠、早产且胎膜完整、因评估羊膜腔微生物/炎症状态行经腹羊膜腔穿刺、存在羊膜腔内感染和/或炎症并接受头孢曲松、克拉霉素和甲硝唑联合抗生素治疗的患者。
  • 部分患者接受了随访羊膜腔穿刺;羊水进行需氧菌、厌氧菌和生殖支原体培养,并针对脲原体属进行聚合酶链反应。
  • 羊膜腔内感染定义为羊水培养或聚合酶链反应阳性;羊膜腔内炎症疑似基于羊水白细胞计数升高或基质金属蛋白酶-8快速试验阳性,最终诊断通过储存羊水中白细胞介素-6浓度(>2.6 ng/mL)确定。
  • 治疗成功定义为羊膜腔内感染和/或炎症根除或分娩≥37周。

主要发现

  • 62例羊膜腔内感染和/或炎症患者中,50例接受了抗生素方案。
  • 50例中29例至少7天未分娩,19例进行了随访羊膜腔穿刺。
  • 随访羊膜腔穿刺的19例中,入院时羊水培养或聚合酶链反应鉴定出微生物者占21%(4/19),其中3例微生物被根除。
  • 随访羊膜腔穿刺的19例中,15例(79%) confirmed羊膜腔内感染/炎症消退,另1例足月分娩但随访羊膜腔穿刺后未能确认炎症消退,故治疗成功16例(84%)。
  • 接受抗生素治疗的50例羊膜腔内感染/炎症患者中,治疗成功16例(32%)。

关键数值与推荐

  • 羊膜腔内感染定义:羊水培养或聚合酶链反应阳性。
  • 羊膜腔内炎症最终诊断:储存羊水中白细胞介素-6浓度>2.6 ng/mL。
  • 治疗成功定义:羊膜腔内感染和/或炎症根除或分娩≥37周。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Intra-amniotic infection is present in 10% of patients with an episode of preterm labor, and is a risk factor for impending preterm delivery and neonatal morbidity/mortality. Intra-amniotic inflammation is often associated with intra-amniotic infection, but is sometimes present in the absence of detectable microorganisms. Antibiotic treatment of intra-amniotic infection has traditionally been considered to be ineffective. Intra-amniotic inflammation without microorganisms has a prognosis similar to that of intra-amniotic infection. OBJECTIVE: To determine whether antibiotics can eradicate intra-amniotic infection or intra-amniotic inflammation in a subset of patients with preterm labor and intact membranes. MATERIALS AND METHODS: The study population consisted of women who met the following criteria: 1) singleton gestation between 20 and 34 weeks; 2) preterm labor and intact membranes; 3) transabdominal amniocentesis performed for the evaluation of the microbiologic/inflammatory status of the amniotic cavity; 4) intra-amniotic infection and/or intra-amniotic inflammation; and 5) received antibiotic treatment that consisted of ceftriaxone, clarithromycin, and metronidazole. Follow-up amniocentesis was performed in a subset of patients. Amniotic fluid was cultured for aerobic and anaerobic bacteria and genital mycoplasmas, and polymerase chain reaction was performed for Ureaplasma spp. Intra-amniotic infection was defined as a positive amniotic fluid culture or positive polymerase chain reaction, and intra-amniotic inflammation was suspected when there was an elevated amniotic fluid white blood cell count or a positive result of a rapid test for matrix metalloproteinase-8. For this study, the final diagnosis of intra-amniotic inflammation was made by measuring the interleukin-6 concentration in stored amniotic fluid (>2.6 ng/mL). These results were not available to managing clinicians. Treatment success was defined as eradication of intra-amniotic infection and/or intra-amniotic inflammation or delivery ≥37 weeks. RESULTS: Of 62 patients with intra-amniotic infection and/or intra-amniotic inflammation, 50 received the antibiotic regimen. Of those patients, 29 were undelivered for ≥7 days and 19 underwent a follow-up amniocentesis. Microorganisms were identified by culture or polymerase chain reaction of amniotic fluid obtained at admission in 21% of patients (4/19) who had a follow-up amniocentesis, and were eradicated in 3 of the 4 patients. Resolution of intra-amniotic infection/inflammation was confirmed in 79% of patients (15/19), and 1 other patient delivered at term, although resolution of intra-amniotic inflammation could not be confirmed after a follow-up amniocentesis. Thus, resolution of intra-amniotic inflammation/infection or term delivery (treatment success) occurred in 84% of patients (16/19) who had a follow-up amniocentesis. Treatment success occurred in 32% of patients (16/50) with intra-amniotic infection/inflammation who received antibiotics. The median amniocentesis-to-delivery interval was significantly longer among women who received the combination of antibiotics than among those who did not (11.4 days vs 3.1 days: P = .04). CONCLUSION: Eradication of intra-amniotic infection/inflammation after treatment with antibiotics was confirmed in 79% of patients with preterm labor, intact membranes, and intra-amniotic infection/inflammation who had a follow-up amniocentesis. Treatment success occurred in 84% of patients who underwent a follow-up amniocentesis and in 32% of women who received the antibiotic regimen.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Yoon BH, Romero R, Park JY, et al. Antibiotic administration can eradicate intra-amniotic infection or intra-amniotic inflammation in a subset of patients with preterm labor and intact membranes. Am J Obstet Gynecol. 2019. PMID: 30928566. doi:10.1016/j.ajog.2019.03.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。